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Abstract
Introduction. In previous studies on different animal models, it was shown that compound N-(N-butylpyrroli-
dine)-2-phenylindole hydrochloride (SS-68) has a broad antiarrhythmic activity. The molecular mechanisms of the 
pharmacological action of SS-68 were chosen as the focus for this study.
Materials and methods. The study of the molecular basis of the pharmacological action of SS-68 was based on 1) 
molecular docking with the determination of the affinity constant for κ1-opioid receptors; 2) recording the fluorescence 
of a culture of cardiomyocytes with the determination of the effect of SS-68 on ionic homeostasis; 3) determining the 
negative chronotropic action in vitro; 4) studying the effect of SS-68 on the transmembrane ion currents of isolated 
unidentified neurons of the large pond snail (Lymnaea stagnalis), orb snail (Planorbarius corneus) and rat hippocampal 
neuron cultures.
Results. 1) In experiments using molecular docking, the affinity of SS-68 for κ1-opioid receptors is significantly higher 
than that of butorphanol, but lower than that of (-)-U-50.488; 2) In spontaneously excited preparations of the right 
atrium, SS-68 causes an irreversible negative chronotropic effect. In experiments on atrial myocardium in rats, SS-68 is 
capable of demonstrating the ability to block M2 and M3-cholinergic receptors; 3) When studying the effects on cardiac 
myocyte ion currents, it was shown that SS-68 has moderate Na+, K+ and Ca2+ – blocking activity; 4) In the study of 
isolated neurons, it was shown that SS-68 influences the electrophysiology of neurocytes in a dose-dependent manner.
Discussion. The study of the molecular basis of the action of SS-68 showed that this compound has a pleiotropic mul-
titarget effect, which consists of, at least, the effect on Na+, Ca2+ and K+-homeostasis of cardiomyocytes and neurons, 
M2-, M3-cholinergic receptors, and κ1-opioid receptors.
Conclusion. From the point of view of molecular pharmacology, SS-68 can be attributed to an antiarrhythmic drug 
with a mixed type of action.
Copyright Bogus SK et al. This is an open access article distributed under the terms of  the Creative Commons Attribution License (CC-BY 4.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
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Introduction
Normal heart rhythm is one of the main conditions for 
maintaining adequate hemodynamics. Cardiac rhythm di-
sorders (arrhythmias) can result from various structural 
and functional abnormalities, such as myocardial infarc-
tion, intoxication, cardiomyopathy, etc. Atrial fibrillation 
(AF) can be distinguished from among the most common 
and clinically significant arrhythmias. According to mo-
dern concepts, AF is a cardiac rhythm disorder characteri-
zed by the absence of atrial systole, which is accompanied 
by arrhythmic contractions of the ventricles (Revishvili 
2015, Camm et al. 2010, Calkins et al. 2009). The proli-
feration of AF in most countries of the world, as well as 
the morbidity and mortality due to it have almost doubled 
(Chugh et al. 2014). In Western Europe, AF is detected in 
the general population already in 2.0–4.7% of cases (Da-
vis et al. 2012). Over the next 3 decades, the number of 
patients with AF in Europe and the United States is expec-
ted to more than double (Naccarelli et al. 2009, Reardon 
et al. 2012, Ball et al. 2013, Wilke et al. 2013). At the 
same time, the proliferation of AF in China is less than 
half of that of the population of Western countries (Zhou 
and Hu 2008), among African Americans in the United 
States it is 45% lower than that of the white population of 
this country (Jensen et al. 2013).
AF occurs in cases when structural and/or electrop-
hysiological disorders lead to anomalous pulse formation 
and/or its spread into the atrium tissue. These disorders 
are due to various pathophysiological mechanisms that 
have not yet been fully studied, and AF is their final result 
(Revishvili 2015, Wakili et al. 2011).
In previous studies by the authors of this paper, a high 
antiarrhythmic potential of SS-68 compound was demon-
strated, which was comparable to the main antiarrhythmi-
cs, such as amiodarone, etacizin, propranolol, etc, in most 
of the models on neutralizing and prophylactic activities 
(Bogus et al. 2018).
In this regard, the molecular mechanisms of the anti-
arrhythmic action of SS-68 were selected as as the focus 
for this study.
Materials and methods
The experiments were carried out in accordance with the 
requirements of GOST ISO/IEC 1704-2009, GOST R ISO 
5725-2002, The Rules of Laboratory Practice approved by 
Order № 708n of the Ministry of Healthcare and Social De-
velopment of the Russian Federation of August 23, 2010, 
and in compliance with The European Convention for the 
Protection of Vertebrates Used for Experiments or Other 
Scientific Purposes (Directive 2010/63/EU). The experi-
ments were conducted in accordance with The Guidelines 
for Pre-clinical Study of Medicinal Products (2012).
Effect of SS-68 on κ1-opioid receptors
To detect the link of SS-68 with the opioid κ1-receptor, 
molecular docking to the specific binding site of this SS-
68 receptor, butorphanol (a partial κ1-receptor agonist) 
and (-)-U-50,488 (a highly selective κ1-receptor agonist) 
was performed. Docking into the X-ray model of the hu-
man κ1-opioid receptor dimer (PDB code 4DJH) (Wu 
et al. 2012) was performed using AutoDock Vina 1.1.1 
package (Trott and Olson 2010) with the calculation of 
the minimum docking energy ΔE (Vasiliev et al. 2016).
The study of the negative chronotropic action of SS-68 
in the intact atrial and ventricular myocardium and 
against the background of its cholinergic stimulation 
in vitro
In the experiments, white nonlinear male rats and male 
mice were used. For electrophysiological experiments, 
three types of preparations were isolated: an isolated 
right atrium operating in its own rhythm, including the 
atrial appendage, the crista terminalis and the intervenous 
region with a sinoatrial node; the right atrium, working in 
the paced rhythm, containing only the atrial appendage 
(the pacemaker area was removed); ventricular myocar-
dium, which is an isolated wall of the right ventricle. The 
preparations that did not contain a pacemaker were sti-
mulated through silver electrodes using a linear insulator 
of stimuli DL-340 (Neuro-biolab, Russia) with a frequen-
cy of 5.5 Hz, and the duration of the stimuli was 2 ms.
The effect of SS-68 on ionic homeostasis of resting and 
stimulated (intact and ischemic) cardiomyocytes
The isolation of cardiomyocytes from the left ventricle 
of the white non-linear white male rats, the procedure of 
loading cells with Fura-2/AM and SBFI probes, the re-
gistration of fluorescence were carried out according to 
the methods described by A. I. Khankoeva et al. (1997, 
1998). The effect of SS-68 on the calcium conductivity 
of the If/HCN channels of the ventricular cardiomyocytes 
was studied in experiments on white non-linear male rats. 
Cardiomyocytes were isolated from the left ventricle of 
the heart, cells were loaded with a Fura2/AM probe, and 
fluorescence was recorded according to the method des-
cribed by A.I. Khankoeva et al. (1997, 1998).
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The effect of SS-68 on Na+-, Ca2+- and K+-ionic cur-
rents and AP 
This was studied in two series of experiments: on isola-
ted and intact unidentified neurons (Kostyuk et al. 1981) 
of the gastropod mollusk – a great pond snail (Lymnaea 
stagnalis), orb snail great ramshorn (Planorbarius cor-
neus) and rat hippocampal neuron cultures. In the first 
series of experiments, the circumesophageal nerve ring 
was prepared from the mollusc’s body, then it was placed 
in a chamber for recording intracellular potentials with 
glass microelectrodes. SS-68 and amiodarone were added 
to external solutions to isolate the corresponding currents. 
Ion current and potential curves were visually evaluated 
on an oscilloscope screen, entered into a computer, and 
printed out. Based on the data obtained by means of the 
computer, the concentration-effect dependency graphs 
were made. The initial values of currents and potentials 
were taken as 100%, and the indicators established under 
the action of the substances were expressed in % of the 
initial values.
Results and discussion
Effect of SS-68 on κ1-opioid receptors in experiments 
using molecular docking
In accordance with the calculated binding constants, the 
SS-68 affinity for κ1-opioid receptors was 4.53 times 
higher than that of butorphanol, and when compared to 
(-)U-50.488 – 2.84 times lower (Table 1).
Table 1 shows that the affinity of SS-68 for κ1-opioid 
receptors is significantly higher than that of butorphanol, 
but significantly lower than that of (-)-U-50.488.
Effect of SS-68 on resting and stimulated (intact and 
ischemic) rat cardiomyocytes on ionic homeostasis
It is known that myocardial ischemia is one of the main 
causes of arrhythmias (Galenko-Yaroshevsky et al. 
2012). Hypoxia-induced shifts of intracellular energy 
metabolism cause changes in transmembrane ion cur-
rents Na+, K+, Ca2+, leading to various disorders of au-
tomatism and conduction of cardiac cells. On this basis, 
the effect of SS-68, as well as of amiodarone and drone-
darone, taken for comparison, on the ionic homeostasis 
of resting and stimulated (intact and ischemic) cardio-
myocytes was studied.
Effect on Na+-channels
Under the conditions of our experiments, the diastolic 
concentration of [Na+]cyt in resting cardiomyocytes was 
7.9±0.5 mM (n=4). Under the conditions of experimen-
tal hypoxia induced by KCN and 2-deoxyglucose, a new 
elevated level of [Na+]cyt was 16.3±1.5 mM (n=6). Thus, 
the difference between the basal levels of Na+ in intact 
and non-oxygenated cardiomyocytes averaged 8.4 mM. 
Preliminary introduction of SS-68, amiodarone, and dro-
nedarone to a final concentration of 10, 25, and 50 μM 
caused a dose-dependent decrease in Na+. At the same 
time, the intensity of the Na+-blocking effect was ap-
proximately equal: SS-68, amiodarone and dronedarone, 
taken at a concentration of 10 μM, significantly (р<0.05) 
inhibited sodium growth by 29, 35 and 27%, respectively. 
It was possible to differentiate the effects of SS-68, amio-
darone, and dronedarone in the experiments on stimulated 
cardiomyocytes. Electrical stimulation of cells during the 
entire period of “chemical” hypoxia led to a significant 
change in [Na+]cyt, both with respect to control samples 
(ΔNa=15.9±2.3 mM) and in comparison with unstimu-
lated myocytes (ΔNa=7.5±1.8 mM). The rise of [Na+]
cyt did not depend on the chosen frequency of electrical 
discharges: stimulation of cells with a current of 0.2 or 
1.0 Hz caused a similar increase in the level of Na+. The 
inhibitory effect of amiodarone on an increase in [Na+]cyt 
depended not only on the dose, but also on the frequen-
cy of electrical stimulation of cardiomyocytes (Fig. 1). It 
should be noted that the depth of the Na+-blocking effect 
of amiodarone on the stimulated cells was significantly 
greater than on the unstimulated ones in the whole ran-
ge of concentrations. Dronedarone inhibited the induced 
[Na+]cyt to a lesser extent, and the dependence of the acti-
vity of this drug on stimulation with a current of various 
frequencies was also detected (Fig. 1). From the data pre-
sented in Figure 1, it is clear that amiodarone-like effect 
on [Na+]cyt is characteristic of SS-68. Depending on the 
stimulation frequency imposed, the degree of inhibition 
of sodium current by SS-68 was significantly different.
Effect on Ca2+-channels
In well-oxygenated cardiomyocytes, the diastolic concen-
tration of free Ca2+ ions in the sarcoplasm is maintained at 
the level of 125–145 nM.
The study of the effects of SS-68, amiodarone, and 
dronedarone on the content of Ca2+ in resting cardiomyo-
cytes did not reveal a significant change in the Ca2+ res-
Table 1. Results of docking SS-68, butorphanol and (-)-U-50,488 substance into the specific κ1-opioid receptor binding site
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ponse of cells within the concentration range of 10–100 
μM. Thus, the obtained data suggest that the substances 
under study do not change the compartmentalization of 
intracellular Ca2+ in unstimulated intact cardiomyocytes. 
During experimental hypoxia induced by incubation of 
cells with D-glucose and KCN for 20 minutes, significant 
changes in the Ca2+ exchange of cardiomyocytes were 
observed. Under the conditions of ”chemical hypoxia”, 
a certain diastolic level of Ca2+ was higher than in intact 
cells (ΔCa=62 nM).
Impact on K+-channels
The limitations when regitering K+-current registration 
using the fluorescent K+ PBFI ion indicator made it possi-
ble to evaluate only qualitative changes in the intracellu-
lar content of [K+]cyt. Electrical stimulation of cardiomyo-
cytes was accompanied by a noticeable decrease in probe 
fluorescence intensity recorded for 2 minutes (Fig. 2).
SS-68, amiodarone and dronedarone influenced both 
the absolute values of fluorescence and the dynamics of 
changes in the PBFI fluorescence (Fig. 3). Depending on 
the severity of the K+-blocking properties, the test sub-
stances can be arranged in a row as follows: SS-68>drone-
darone>amiodarone. Thus, SS-68 and, taken as reference 
Figure 1. Comparative effectiveness of the Na+-blocking effect 
of SS-68 (a), amiodarone (b) and dronedarone (c) under condi-
tions of experimental hypoxia.
Figure 2. Fluorescence (510 nm) of resting (1) and stim-
ulated (2) (with electrical impulses of 1.0 Hz) cardiomy-
ocytes.
Figure 3. Dynamic pattern of PBFI probe fluorescence of the during electrical stimulation of cardiomyocytes without 
SS-68 (1) and with SS-68 (2), dronedarone (3) and amiodarone (4), taken at a concentration of 50 μM.
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drugs, amiodarone and dronedarone under conditions of 
unstimulated cardiomyocytes (both intact and ischemic) 
cause an almost equivalent dose-dependent decrease in 
their [Na+]cyt concentration.
SS-68 has an indirect effect on the Ca2+ homeostasis 
of cardiomyocytes by blocking the entry of Na+ into the 
cell. In contrast to the effect of SS-68, the effect of ami-
odarone and dronedarone on [Ca2+]cyt in cardiomyocytes 
is a combination of its direct effect on the Ca2+ exchange 
and its indirect action, realized through the mechanism of 
inhibiting Na-dependent elevation of [Ca2+]cyt. In terms of 
its ability to have a K+-blocking effect, SS-68 is superior 
to dronedarone and amiodarone.
Study of the negative chronotropic action of SS-68 
in the intact atrial and ventricular myocardium and 
against the background of its cholinergic stimulation 
in vitro
The parameters of electrical activity most sensitive to the 
action of SS-68 were APD
50
 (action potential duration at 
50%) and APD90 (action potential duration at 90%). Expe-
riments showed that, unlike all other concentrations, the 
smallest of the used concentration cuased not an incre-
ase of APD, but, on the contrary, a small shortening of 
AP, which was statistically significant both in ventricu-
lar myocardial preparations (Figs. 4 A, 6 A) and in the 
atria, working in their own rhythm (Fig. 5, 7). In the atria, 
which worked in the paced rhythm, a significant decrease 
in APD was observed only for 50% of the repolarization 
(Figs. 4 E, 6 C). However, in the atrial myocardium, when 
washing-off from 10-6 M of SS-68, instead of the expected 
gradual return of APD to the control values, an increase in 
APD was observed compared to control, which was then 
not eliminated even after 20 min of washing-off (Figs. 6 
D, 7 B). In the ventricular myocardium, this phenomenon 
was not observed. In the other concentrations, SS-68 
caused the same type of effects – an increase in APD90 
and APD
50
, which showed pronounced dose-dependence 
(Figs. 6 B and D, 7 F-H, 5 B-D, 6 A and B, 7 A). At the 
same time, during washing-off, these effects were always 
significantly enhanced (Figs. 6 B and D, 7 B). For exam-
Figure 4. Original records of right ventricular myocardial AP (A–D), as well as of the right atrium operating in a paced rhythm, 
(E–H) in normal conditions and when applying SS-68 at concentrations of 10–6 (A), 5×10-6 (B), 10-5 (C) and 5×10-5 M (D).
Key. The control record is shown in black line, the record at the time of the maximum effect of SS-68 is red (ventricular myocardi-
um) or orange (atrial myocardium). In Figures D and H green lines show the records of electrical activity during the washing off the 
drug. Records are taken from two representative experiments.
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ple, if in the ventricular myocardium and in the atria that 
worked in their own rhythm, 5×10-6 M of SS-68 did not 
cause a significant lengthening of AP, then after washing 
off the substance in such a concentration, a marked incre-
ase in APD
50
 and APD90 was observed (Figs. 6 B, 7 B).
The most pronounced effects developed under the in-
fluence of the highest concentration used (5×10–5 M), and 
especially during washing-off from it. In addition to the 
pronounced extension of AP, SS-68 in this concentration 
led to a sharp decrease in the amplitude of AP in preparati-
ons that worked in the paced rhythm (by 27.6±4.3% in the 
ventricular myocardium, by 24±4.4% in the atrial myo-
cardium), linked with a decrease in membrane potential 
(by 5.2±0.8 mV and 4.4±0.9 mV, respectively). During 
washing-off, in 5 ventricular preparations and in 4 out of 6 
atrial preparations working in the paced rhythm, complete 
inhibition of electrical activity happened – instead of AP, 
myocardial cells generated only an electrotonic response 
(Figs. 4 D and H).
The effect of SS-68 on Na+, Ca2+ and K+ transmem-
brane ion currents and the action potential of isolated 
unidentified gastropod neurons and rat hippocampal 
neuron cultures
It was found out that under the influence of SS-68 and 
amiodarone, used as a reference drug, at concentrations of 
1 and 10 μM, the amplitude of the sodium current chan-
ged slightly, while SS-68 increased slightly (by 3–5% of 
control), and amiodarone did not change or slightly redu-
ced its amplitude (Fig. 8 A). At concentrations of 100 and 
1000 μM, current-dependent inhibition of current occur-
red, while SS-68 inhibited it to a greater extent than ami-
odarone. The recovery of current after the action of SS-68 
Figure 5. Original recordings of right atrial AP, working in its own rhythm, in normal condition and when applying SS-68 at concentrations of 
10-6 (A), 5×10-6 (B), 10-5 (C) and 5×10-5 M (D).
Key. The control record is shown in black line, the record at the time of the maximum effect of SS-68 is blue. In Figure D, green indicates the 
record of electrical activity during the washing off the drug (at the moment before withdrawal of the drug). Records are taken from one repre-
sentative experiment.
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Figure 6. Dose-dependence of APD changes under the influence of SS-68 (A, C) and during washing-off (B, D) in preparations of 
the right ventricular wall (A, B) and preparations of the right atrium, working in a paced rhythm (C, D).
Key. Bar charts: green – APD90 changes, red – APD50. * Reliability of effect (p<0.05, Wilcoxon test).
was very slow (over 15 minutes), and after amiodarone 
– faster (within 5–7 minutes up to 70% of control), which 
indicates the greater binding strength of SS-68 molecu-
les to membrane structures (or ion channels) compared to 
amiodarone.
The nature of the change in sodium currents under the 
influence of SS-68 is shown in Figure 8 B (decrease in 
amplitude). The peak of current-voltage characteristics of 
the membrane for sodium channels under the influence of 
SS-68 slightly (up to 5 mV) shifted to the right (towards 
the depolarization of the membrane) along the potential 
axis (Fig. 8 C), which indicates a change in the potential 
of the surface charge of the membrane created by fixed 
charges. The kinetics of sodium current development un-
der the influence of amiodarone did not change, and there 
was no shift in the maximum current-voltage characteris-
tic of the membrane. When registering the current-voltage 
characteristic of the membrane for sodium and potassium 
channels, the corresponding currents were simultaneously 
inhibited to approximately the same degree (Fig. 8 D).
Under the influence of amiodarone and SS-68, the cal-
cium current amplitude only decreased dose-dependently 
and reversibly, while amiodarone inhibited it to a lesser 
extent (Fig. 8 A). The reversibility of the inhibition effects 
after the washing-off almost reached the original values, 
with amiodarone being washed off 2–3 times faster (in 
5–7 minutes) than SS-68 (in 15–25 minutes). The kinetics 
of the development of calcium current under the influence 
of amiodarone was slightly accelerated (Fig. 8 C), but did 
not change under the influence of SS-68 (Fig. 8 B). Under 
Figure 7. Dose-dependent changes in APD and duration cycle 
under the influence of SS-68 (A) and during washing-off (B) in 
right atrial preparations, working in their own rhythm.
Key. Bar charts: green – APD90 changes, red – APD50, blue – 
duration cycle. * - Reliability of effect (p<0.05, Wilcoxon test).
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the influence of both substances, the maximum of the cur-
rent-voltage characteristics did not shift along the potenti-
al axis (Fig. 9 D), i.e. the potential of the fixed charges of 
the membrane did not change. The nature of the effects of 
amiodarone and SS-68 on slow potassium channels (Fig. 
8 A) resembled the effect on sodium channels, and for 
SS-68 it was two-phase; at a concentration of 1 μM, the 
amplitude of the current increased slightly, and at higher 
levels it decreased (at a concentration of 1000 µM – by 
15–20%), under the influence of amiodarone, the changes 
were monophasic (inhibition). In general, the inhibition 
of current by SS-68 was stronger than by amiodarone.
The restoration of the currents in the process of 
washing off neurons was similar for calcium and sodium 
currents – more slowly for SS-68. Under the influence of 
both substances at concentrations of 100 and 1000 μM, 
inactivation of the potassium current accelerated. There 
were no shifts of the current-voltage characteristics of the 
channels, that is, the potential of the fixed charges of the 
membrane near the potassium channels did not change. 
The nature of the effect of SS-68 and amiodarone on fast 
potassium currents outwardly resembled their effect on 
sodium (monophase), there were no changes in the kine-
tics of their development (Figs. 10 C and D in the left part 
of the figures). For comparison, the general nature of inhi-
biting incoming sodium and calcium ion currents, as well 
as fast and slow potassium ion currents under the influen-
ce of SS-68 is shown in Figure 11 A. At the very end of 
the recording, the capacitance currents of the membrane 
poining downward and arising in response to shutdown of 
the linearly increasing offset potential.
In a small series of experiments on 4 neurons of a pond 
snail, a slow potassium current was recorded, while SS-
68 at a concentration of 100 μM was supplied not from 
the outer part of the neuron membrane, but was injected 
inside with dialysis fluid, and its effect was tested from 
inside the cell. A typical reaction of one of the neurons is 
shown in Figure 11 B. It turned out that SS-68, inhibiting 
current in the same concentration from the outside (Fig. 
11B, 4th curve from top under the arrow), did not inhibit 
current from inside (Fig. 11 B, the two upper curves – 
control and intracellular action, the third curve from top 
– washing SS-68 off from the outside). It can be assumed 
that potassium channels are available for binding to SS-68 
only in case of extracellular action: either through mem-
brane lipids, or after entering the channel from the out-
side when it is opened. Similar reactions were recorded 
for sodium and calcium currents. To control and compare 
the intracellular action of SS-68 with that of other sub-
stances under similar conditions, the effect of lidocaine on 
potassium ion channels from inside and outside the cell 
at a concentration of 1000 μM was tested. It was shown 
that lidocaine in intracellular action, as compared with 
extracellular action, turned out to be ineffective. Washing 
lidocaine off from outside led to a gradual recovery of 
current. It is known that tetraethylammonium (TEA) ef-
Figure 8. Changes in the sodium current of the pond snail neurons under the influence of SS-68 (n=6) and amiodarone (n=6).
Key. A – concentration-effect relations under the influence of SS-68 and amiodarone. B – changes in the amplitude and kinetics of 
the current under the influence of, SS-68, curves from bottom to top: 1 – 1 μM, 2 – control, 3 – SS-68 100 μM, 4 – 1000 μM. B – 
current-voltage characteristics of sodium channels, from bottom to top: 1 – control, 2 – 1 μM, 3 – 10, 4 – 100, 5 – 1000 μM. G – the 
same for Na-calcium channels: 1 – control, 2 – 1 μM, 3 – 10, 4 – 100, 5 – 1000. On the x-axis: A – concentration, B – time, C and 
D – sawtooth offset of membrane potential from –40 to 50 mV for 10 and 40 ms; on the ordinate axis – ion current (A: I – under the 
influence of the substance, I0 - before the influence; confidence intervals at p=95%; B and C: I
Na
 - sodium current).
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Figure 9. Changes in the calcium current of the pond snail neurons under the influence of SS-68 (n=7) and amiodarone (n=6).
Kew. A – concentration-effect relations. B – changes in the amplitude and kinetics of the current under the influence of SS-68, curves 
from bottom to top: 1 – control, 2 – 10 μM, 3 – 100, 4 – 1000. C –changes in the amplitude and kinetics of the current under the 
influence of amiodarone; curves from bottom to top: 1 – control, 2 – laundering, 3 – 100 μM. D – current-voltage characteristics 
under the influence of SS-68, curves from bottom to top: 1 – control, 2 – 10 μM, 3 – 100, 4 – 1000. On the x-axis: A – concentration 
of anesthetics, B and C – time, D – sawtooth offset of membrane potential from –40 to 50 mV; on the ordinate axis – ion current (A: 
I – under the influence of the substance, I0 – before the influence; confidence intervals at p=95%; ICa – calcium current).
Figure 10. Changes in potassium slow and fast currents of pond snail neurons under the influence of SS-68 (n=6 and n=5, respec-
tively) and amiodarone (n=6 and n=5).
Key. A and B – concentration-effect relations for slow and fast potassium channels. B – changes in the amplitude and kinetics of 
current; curves from top to bottom under the arrow: 1 – 1 μM, 2 – control, 3 – 10 μM, 4 – 100 μM, 5 – 1000 μM. C - current-voltage 
characteristics: 1 – control, 2 – washing-off, 3 – SS-68 100 μM, 4 – SS-68 1000 μM. D is the same as B; curves under the arrow: 
1 – control, 2 – 10 μM, 3 – 100, 4 – 1000 μM. On the x-axis: A and C – concentration, B and D – time; on the ordinate axis – ion 
current (A and B: I – under the influence of the substance, I0 – before the influence; confidence intervals at p=95%; B and D: I Ks 
– slow and I Kf – fast potassium currents).
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fectively inhibits potassium ion currents in case of exter-
nal and intracellular actions. Indeed, TEA at a concentra-
tion of 10 mM from the inside inhibited by about half the 
initial part of the current associated with fast potassium 
channels, and the current of slow potassium channels – 
by about 25%. The action was reversible, but rather long 
(after 13 min – current was partially recovered, and after 
30 min – current was recovered more completely).
Under the influence of SS-68 at concentrations of 1, 10 
and 100 μM, a slight dose-dependent hyperpolarization of 
1-3 mV was observed in neurons, whereas when using this 
substance at a concentration of 1000 μM there was only 
minor depolarization (Fig. 11 C, fragment 3). Against the 
background of hyperpolarization, a decrease in the impul-
se activity of neurons occurred. With the development of 
cell depolarization, there was a slight increase in impulses 
in strings of APs with a decrease in the AP amplitude and 
with a slight increase in their duration. It should be noted 
that these are phenomena of the usual potential-dependent 
changes in the parameters of AP. But since the inhibition 
of ion currents occurs at SS-68 concentrations of 100 and 
1000 μM, changes in the parameters of AP can be additi-
onally determined by this circumstance. The decrease in 
the AP amplitude is clearly shown in Figures 11 D and 
E – up to the cessation of their generation. However, AP 
could be caused by passing a depolarizing current through 
a microelectrode.
Effect of SS-68 on ionic currents and the action poten-
tial of rat hippocampal neuron cultures
The effect of SS-68 on induced AP in the hippocampal 
neurons
Figures 12 and 13 show the records of changes in the 
potential of neurons that generate, in control, strings of 
13–11 APs with a frequency of 35–15 Hz. It was shown 
that in all cases in the presence of 1–3 μM of SS-68, the 
frequency of APs in the string decreased and the duration 
of individual APs increased due to inhibition of the acti-
Figure 11. Changes in ion currents and intracellular potentials of neurons of the pond snail and great ramshorn under the influence 
of SS-68.
Key. A – current-voltage characteristics of the membrane, under the arrow from top to bottom: 1 – 1 μM SS-68, 2 – control, 3 – SS-
68 10 μM, 4 – 100, 5 – 1000; B – changes in the amplitude and kinetics of potassium currents during extra- and intracellular action; 
curves from top to bottom under the arrow: 1 – control, 2 – 100 μM шт case of intracellular action, 3 – outside washing-off, 5 – 100 
μM outside; C – the dynamics of changes in the resting potential and the electrical activity of the neuron of the orb snail under the 
influence of SS-68 in various concentrations: 1 – control, 2 – 1 μM, 3 – 10, 4 – 100, 5 – 1000. On the x-axis: time, one cell=1 min; 
On the ordinate axis - membrane potential, one cell=5 mV; D – the same as C: 1 – at the beginning of the action of 100 μM, then – 
of 1000 μM and cessation of activity (on the x-axis: time, one cell=1 min; on the ordinate axis – membrane potential, one cell=15 
mV) ; E – AP parameters: at 100 and 1000 μM (on the x-axis: time, one cell=20 ms; on the ordinate axis – membrane potential, 
one cell=15 mV); A and B: on the x-axis A – sawtooth offset of membrane potential from –30 to 50 mV in 50 ms, B – time; on the 
ordinate axis – ion current.
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Figure 13. The first 3 APs out of 10 generated by neuron 2 in 
response to the depolarizing impulse. In the presence of 1–3 
μM of SS-68, the duration of APs increases due to a decrease 
in hyperpolarization and inhibition of the slow phase of depo-
larization.
vity of K+-channels participating in the second phase of 
repolarization and the third phase of slow depolarization 
(trace hyperpolarization). The number of APs in the string 
is reduced due to the rapid vibration reduction. Figure 14 
shows the induced single APs of the neuron before and 
after the application of SS-68. It shows that even at a con-
centration of 5 μM, SS-68 inhibits the first phase of ra-
pid depolarization, which indicates a partial blockade of 
Na+-channels. This leads to an increase in the excitability 
threshold and inhibition of the nerve conduction velocity. 
There is also a strong inhibition of K+ channels determi-
ning the speed of the repolarization phase.
The effect of SS-68 on ion currents in the mode of 
fixing the potential on the neuron membrane
To determine the type of ion currents, the inhibition 
of which leads to the observed changes in AP, measure-
ments were performed in the mode of fixing the potential. 
When registering the current to measure the activity of 
Na+-channels, the cell was depolarized to -30mV (Fig. 
15A), then to register the activity of K+-channels, the 
depolarization was increased to +50mV (Fig. 15B). The 
measurements were carried out in the presence of various 
concentrations of SS-68. Figures 15 A and B show that 
Figure 12. Depolarization-induced (300 pA, lasting for 500 ms) 
AP series in neuron. Under the influence of 3 μM of SS-68, the 
frequency decreases from 35 to 17 Hz. The culture age is 15 
days.
Figure 14. In response to a depolarizing impulse of 300 pA last-
ing for 50 ms, the rat hippocampal neuron generates one AP in 
the control (1) and in the presence of 5 μM of SS-68 (2).
Figure 15. A) – Change in K+-current in a neuron in response 
to depolarization down to -30 mV in control and in the presence 
of 1, 2, 10 and 50 μM of SS-68. The culture age is 8 days. B) 
-Change of K+-current in the same neuron in response to depo-
larization up to +50 mV in the control and in the presence of 1, 
2, 5, and 10 μM of SS-68. The culture age is 8 days.
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in low concentrations (1–5 μM), SS-68 inhibits the fast 
and slow components of K+-current of delayed rectifica-
tion. As the concentration increases, the Na+-current is 
also inhibited. When the concentration is increased to 50 
μM, SS-68 completely blocks the Na+-potential-depen-
dent channels and the generation of sodium current. Thus, 
SS-68 in low concentrations selectively blocks repolari-
zation-mediating K+-currents of delayed rectification of 
neurons, which leads to prolongation of APs, a decrease 
in the generation rate AP pulses during neuron string acti-
vity, and partially blocks Na+-channels, somewhat inhibi-
ting the very first phase of rapid depolarization.
Discussion
Effect on opioid receptors
Based on the results presented in Part 1 of the article, it 
can be assumed that SS-68 in low doses has properties 
of class III antiarrhythmic and in relatively large doses 
– those of II, III and IVclasses according to the Vaug-
han-Williams classification. At the stage of studying an-
tiarrhythmic activity, it was suggested that SS-68 could 
also have an agonistic effect on opioid receptors. Further, 
this served as the basis for the study of SS-68 in this di-
rection.
In molecular docking experiments, the affinity of SS-
68 for κ1-opioid receptors is significantly higher than 
that of butorphanol, but lower than that of (-)-U-50.488. 
Therefore, it can be argued with a certain probability that 
the antiarrhythmic efficacy of SS-68 in low doses (20 and 
partially 50 μg/kg) in heart rhythm disturbance conditions 
against the background of vagus nerve stimulation is re-
alized through an agonistic effect on κ1-opioid receptors.
In the study of negative chronotropic action in vitro, 
it was found that SS-68 causes two types of effects similar 
in the atrial and ventricular myocardium of rats: reversi-
ble acceleration of the AP repolarization phase and a more 
pronounced irreversible slowing of the repolarization al-
ong with a decrease in the amplitude of AP and resting 
potential. When using SS-68 in increasing concentrations, 
the effects of the second type mask the acceleration of 
repolarization.
In the spontaneously excited preparations of the right 
atrium, SS-68 causes an irreversible negative chronot-
ropic effect, which is partly a consequence of the deve-
lopment of the irreversible effects of SS-68 in the working 
myocardium. The mechanism of action of SS-68 appears 
to include a complex effect on a range of ion currents, in 
particular, inhibition of IK and direct inhibition of INa.
SS-68 in the concentration range of 5×10-6-5×10-5 M 
induces in the SAN preparations of mice a dose-depen-
dent slowdown of the rhythm induced by a decrease in 
the speed of slow diastolic depolarization, as well as a 
decrease in the rate of rising slope steepness of the acti-
on potential. The high concentration (5×10–5 M) of SS-68 
entails a decrease in the excitability of the cells of the 
central part of the SAN and the irregularity of the electri-
cal activity.
In the working atrial myocardium on the background 
of cholinergic stimulation, 10-5 M of SS-68 causes a big-
ger increase in the duration of AP, but less pronounced 
slowing of the sinus rhythm than in normal conditions. 
Against the background of 10–5 M of SS-68, carbachol 
(10–7 M) induces effects that are somewhat weaker than in 
normal conditions.
In experiments on the atrial myocardium of rats, SS-68 
is able to reduce both the effect of joint activation of M2- 
and M3- cholinergic receptors and the effect of selective 
stimulation of M3- cholinergic receptors.
When studying the effect of SS-68 on the content of 
Na+, Ca2+ and K+ in cardiomyocytes, it was found that 
in conditions of unstimulated intact and ischemic cardio-
myocytes of rats, SS-68, amiodarone and dronedarone, 
used as reference drugs, cause an almost similar dose-de-
pendent decrease in their [Na+]cyt concentration, and in sti-
mulated ones – have an inhibitory effect on the increase in 
[Na+]cyt, both depending on the dose and on the frequen-
cy of their electrical stimulation, and the intensity of the 
Na+-blocking effect of amiodarone is significantly grea-
ter than on unstimulated cardiomyocytes; SS-68 exhibits 
amiodarone-like effect; Dronedarone inhibits [Na+]cyt to a 
lesser extent and, like amiodarone and SS-68, is more ac-
tive on stimulated cardiomyocytes.
SS-68 has an indirect effect on the Ca2+ homeostasis of 
cardiomyocytes by blocking the entry of Na+ into the cell. 
Unlike the effect of SS-68, the effect of amiodarone and 
dronedarone on [Ca2+]cyt in cardiomyocytes consists of its 
direct effect on the Ca2+ exchange and the indirect effect 
realized through the mechanism of inhibiting the Na-de-
pendent rise in [Ca2+]cyt.
By ability to exert a blocking effect on the K+ homeo-
stasis in cardiomyocytes, SS-68 is superior to amiodarone 
and dronedarone.
SS-68 and ivabradine, used as a reference drug, in ex-
periments on resting and stimulated cardiomyocytes of 
rats almost similarly inhibit the transport of Ca2+ through 
If/HCN channels. The change of Ca2+ diastolic current 
under the influence of SS-68 through these channels is 
direct. One of the pathogenetic mechanisms of atrial ar-
rhythmogenesis can be the conduction of Ca2+ current 
through the If channel, confirmed by activation of the 
cAMP channel and inhibition by the If-channel blocker 
with ivabradine and SS-68.
The experimental approach to determining the con-
ductivity of Ca2+ through If/HCN channels proposed in 
the present paper can be used in further studies of the 
pathogenetic mechanisms of atrial arrhythmias and their 
possible pharmacological correction. The presence of 
Ca2+-current in the If/HCN channel, as a universal cell 
messenger, is important for understanding the mechanis-
ms of development of cardiovascular diseases, as well as 
in studies of the arrhythmogenic properties of the If.
SS-68 and amiodarone have a pronounced membranot-
ropic effect, which is manifested in changes in ion currents 
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(through the potential-controlled ion channels of the iso-
lated neurons of the pond snail) and their membrane po-
tentials. In low concentrations (1 and 10 μM), SS-68 causes 
activation of Na+ and K+ slow currents, acceleration of inac-
tivation of K+-currents and slight hyperpolarization of neu-
rons; in high (100 and 1000 μM) induces dose-dependent 
and approximately equivalent inhibition of all investigated 
ion currents which was manifested to a greater extent than 
in amiodarone; the latter, compared with SS-68, inhibits ion 
currents to a lesser extent, but it is washed off faster.
In experiments on isolated hippocampal neurons of 
rats, SS-68 at low concentrations (up to 2-3 μM) selec-
tively blocks the repolarization-mediating K+-currents of 
delayed rectification, which leads to prolongation of acti-
on potential, a decrease in the AP generation rate during 
neuron string activity, and in high concentrations it par-
tially blocks Na+-channels, somewhat inhibiting the first 
phase of rapid depolarization.
Conclusions
Thus, SS-68 compound is a promising pharmacological 
agent with a high preventive and arresting effects towards 
various electrophysiological disorders in the heart. From the 
point of view of molecular pharmacology, SS-68 can be re-
ferred to an antiarrhythmic drug with a mixed type of action.
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